The Department of Veterans Affairs (VA) awarded a $352,608.54 firm-fixed-price purchase order to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for reagents and supplies for the GeneXpert instrument. The contract has a base period plus one option year, with performance from December 1, 2023 through November 30, 2025. This award is based on solicitation 36C24524Q0102, which sought to procure specific Cepheid molecular test kits, collection devices, and other supplies to support testing at the Baltimore VA Medical Center. The contract does not have a set-aside designation. Cepheid has received numerous prime federal contracts and subcontracts related to providing diagnostic testing equipment, reagents, and support services to VA and other agencies.